NDC 55566-1010 – Fyremadel
Ganirelix Acetate 250 ug/.5mL · Injection, Solution · Subcutaneous
Product NDC55566-1010
Product details
- Brand name
- Fyremadel
- Generic name
- Ganirelix acetate
- Labeler
- Ferring Pharmaceuticals Inc.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- ANDA · ANDA204246
- Marketed since
- February 28, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Gonadotropin Releasing Hormone Receptor Antagonist
Active ingredients
- Ganirelix Acetate 250 ug/.5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 55566-1010-1 | 1 BLISTER PACK in 1 CARTON (55566-1010-1) / 1 SYRINGE in 1 BLISTER PACK / .5 mL in 1 SYRINGE | Feb 28, 2022 |
Recalls mentioning this NDC
- D-0569-2023 May 3, 2023 · Class II
Presence of Particulate Matter: A piece of glass was found in a prefilled syringe.